| http://www.w3.org/ns/prov#value | - Remarks: Other factors not covered by our analysis, such as drug availability, cost, and ability to monitorRemarks: We place a high value on the prevention the anticoagulant effect may in???uence the choice ofof venous limb gangrene and a low value on the cost agent.
|
